Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Jan 24.
Published in final edited form as: Biochemistry. 2012 Jan 9;51(3):761–768. doi: 10.1021/bi201446z

Channel-Opening Kinetic Mechanism of Wild-Type GluK1 Kainate Receptors and a C-Terminal Mutant

Yan Han 1,, Congzhou Wang 1, Jae Seon Park 1, Li Niu 1,*
PMCID: PMC3272274  NIHMSID: NIHMS349172  PMID: 22191429

Abstract

GluK1 is a kainate receptor subunit in the ionotropic glutamate receptor family and can form functional channels when expressed, for instance, in HEK-293 cells. However, the channel-opening mechanism of GluK1 is poorly understood. One major challenge to studying the GluK1 channel is its apparent low surface expression, which results in a low whole-cell current response even to a saturating concentration of agonist. The low surface expression is thought to be contributed by an endoplasmic reticulum (ER) retention signal sequence. When this sequence motif is present as in the wild-type GluK1-2b C-terminus, the receptor is significantly retained in the ER. Conversely, when this sequence is lacking, as in wild-type GluK1-2a (i.e., a different alternatively spliced isoform at the C-terminus) and in a GluK1-2b mutant (i.e., R896A, R897A, R900A and K901A) that disrupts the ER retention signal, there is higher surface expression and greater whole-cell current response. Here we characterize the channel-opening kinetic mechanism for these three GluK1 receptors expressed in HEK-293 cells by using a laser-pulse photolysis technique. Our results show that the wild-type GluK1-2a, wild-type GluK1-2b and the mutant GluK1-2b have identical channel-opening and channel-closing rate constants. These results indicate that the C-terminal ER retention signal sequence, which affects receptor trafficking/expression, does not affect channel-gating properties. Furthermore, as compared with the GluK2 kainate receptor, the GluK1 channel is faster to open, close, and desensitize by at least two-fold, yet the EC50 value of GluK1 is similar to that of GluK2.


Kainate receptor channels are involved in regulating both excitatory and inhibitory neurotransmission.13 Abnormal function of kainate receptors, however, has been implicated in some neurological disorders, such as epilepsy.46 Kainate receptors have 5 subunits, named as GluK1-5.7 GluK1 (previously known as GluR5),8 the focus of this study, is alternatively spliced at the C-terminus, producing various receptor isoforms.8, 9 Among them, GluK1-2b is 49 amino acids longer than GluK1-2a, the shortest, whereas GluK1-2c, the longest, is generated by an in-frame insertion of nucleotides encoding for an additional 29 amino acids, into the GluK1-2b sequence (Figure S1).9

To date, the understanding of the biophysical properties of kainate receptors at a molecular level emerged largely from studies of GluK2.2 The kinetic properties of GluK1 receptors are not well understood, in part because of their intrinsic low surface expression. GluK1, like the other kainate receptor subunits GluK2 and 3, can form homomeric channels in a heterologous expression system.8, 9 However, GluK1, when expressed in human embryonic kidney (HEK-293) cells, for instance, produces a low current response to even a saturating concentration of agonist.912 In a study of GluK1, Ren et al.10 identified an endoplasmic reticulum (ER) retention signal from the intracellular C-terminus of GluK1-2b. The motif consists of a series of positively charged residues or mostly arginines. Among them, Arg896 is critical for its ER retention and low surface expression.10 If this ER retention motif in the wild-type GluK1-2b is disrupted by mutation, the ER exit of the receptor is promoted and the surface delivery is enhanced, resulting in a larger whole-cell current.10 A sizeable whole-cell current response is essential for studying the biophysical properties of a receptor channel. For instance, properties of the closed-channel conformation are studied at a low agonist concentration, which evokes low current response.13 A low current response becomes even lower in the presence of an inhibitor. Furthermore, a sizeable whole-cell current response can serve as a functional output at cell surface for studying trafficking of kainate receptors, which is involved in affecting neurotransmission during synaptic plasticity and neuronal development.113

Here we focus on the wild-type GluK1-2b receptor subunit, wild-type GluK1-2a (which does not contain the ER retention signal, unlike the wild-type GluK1-2b) and a mutant GluK1-2b (R896A, R897A, R900A, K901A). GluK1-2a is a commonly used wild-type isoform representative of GluK1 in various studies.9, 11, 12, 14, 15 Mutations of mostly arginines within the ER retention signal located in the C-terminus of GluK1-2b are known to abolish ER retention.10 Therefore, the mutant GluK1-2b receptor lacks the ER-retention signal and is expected to express better than the wild-type GluK1-2b in HEK-293 cells for electrophysiological experiments. The questions we set out to address in this study are: (a) what are the kinetic and equilibrium constants for the opening of the GluK1 channels; (b) does a mutation in the ER-retention signal or the trafficking motif affect these constants; (c) does a GluK1 isoform that lacks the entire ER retention signal (i.e., GluK1-2a) have different channel-opening kinetic constants? To measure these channel-opening constants, we used a laser-pulse photolysis technique with a photolabile precursor of glutamate or caged glutamate,16 which provides ~60 microsecond (μs) time resolution.1719

EXPERIMENTAL PROCEDURES

Expression of cDNAs and Cell Culture

The DNA plasmids encoding the wild-type GluK1-2a(Q), wild-type GluK1-2b(Q) and the mutant GluK1-2b (R896A, R897A, R900A, K901A) were respectively from Peter Seeburg and Geoffrey Swanson. The 3132-bp fragment harboring the open reading frame that encodes GluK1-2a was cloned into pcDNA3.1(+). The cDNA plasmids were propagated through an E. coli host (DH5α) and purified using a QIAGEN kit. A receptor was transiently expressed in HEK-293 cells by a calcium phosphate method, as previously described.17 The HEK-293 cells were also cotransfected with a DNA plasmid encoding green fluorescent protein and another plasmid encoding the SV40 large T-antigen.17 The weight ratio of the DNA plasmid for a receptor to green fluorescent protein to large T-antigen was 20:1:2, with the receptor DNA plasmid being 20 μg per 35-mm Petri dish. The cells were cultured in Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum and 1% penicillin in a 37 °C, 5% CO2, humidified incubator. Transfected cells were allowed to grow for at least 48 h before recording.

Whole-Cell Current Recording

Electrodes for whole-cell recording were made from glass capillaries from World Precision Instruments (Sarasota, FL) and fire polished. The electrode had a resistance of ~3 MΩ when filled with the pipette solution. The pipette solution contained (in mM) 110 CsF, 30 CsCl, 4 NaCl, 0.5 CaCl2, 5 EGTA, and 10 HEPES (pH 7.4 adjusted by NaOH). The external cellular solution contained (in mM) 150 NaCl, 3 KCl, 1 CaCl2, 1 MgCl2, and 10 HEPES (pH 7.4 adjusted by NaOH). Green fluorescence in the transfected cells was visualized using a Carl Zeiss Axiovert S100 microscope equipped with a fluorescent detection system (Thornwood, NY). The glutamate-induced whole-cell current was recorded using an Axopatch200B amplifier at a cutoff frequency of 2–20 kHz by a built-in, 4-pole low-pass Bessel filter and was digitized at 5–50 kHz sampling frequency using a Digidata 1322A from Molecular Devices (Sunnyvale, CA). Data were acquired by using pClamp 8 software (also from Molecular Devices). All data were collected from the transfected HEK-293 cells voltage-clamped at −60 mV and 22 °C.

Laser-Pulse Photolysis Measurement

In the laser-pulse photolysis measurement, γ-O-(α-carboxy-2-nitrobenzyl)glutamate or caged glutamate (Invitrogen)1618 was photolyzed to liberate glutamate for measuring the rate of GluK1 receptor channel opening. We also used another caged glutamate, i.e., 4-methoxy-7-nitroindolinyl-glutamate,20 for some of our measurements. We tested the two caged glutamate compounds extensively with several glutamate receptor channels and found no difference in the rate constant measurement. Caged glutamate (or free glutamate) was applied to an HEK-293 cell suspended in the extracellular solution by using a U-tube flow device.17, 18 The cell was equilibrated with caged glutamate for 250 ms before being irradiated by a laser pulse. A Minilite II pulsed Q-switched Nd:YAG laser (Continuum, Santa Clara, CA), tuned by a third harmonic generator, produced single pulses of 8 ns at 355 nm. The laser light was introduced to a cell via a fiber optic, and the power was adjusted to 200–800 μJ. For a laser-pulse photolysis measurement of a channel-opening kinetic rate constant, we also used at least two known concentrations of free glutamate with the same cell before and after a laser flash to calibrate the concentration of photolytically released glutamate.17, 18, 21 The current amplitudes obtained from flow measurements were compared with that of the laser measurement with reference to the dose-response relationship. The flow measurement also allowed us to monitor any potential damage to the receptors and/or the cell for successive laser flashes with the same cell.

Data Analysis

In the laser-pulse photolysis measurement of the channel-opening reaction, we observed that the whole-cell current rise followed a single-exponential rate process (>95%) over the entire range of ligand (glutamate) concentrations that we were able to measure (i.e., 60–400 μM glutamate or ~4% – 52% of the fraction of the open-channel population; see the dose-response curve in the Results). Therefore, the observed rate constant of channel opening, kobs, was empirically determined by eq 1

It=IA(1ekobst) (1)

where It and IA represent the whole-cell current amplitude at time t and the maximum current amplitude, respectively. To describe the relationship between kobs and agonist concentration, we introduced a general mechanism of channel opening.17, 18, 21

A+nLK1ALnkclkopAL¯n

Here, A stands for the active, unliganded form of the receptor, L the ligand or glutamate, ALn the closed-channel state with n ligand molecules bound, and ALn¯ the open-channel state. The number of glutamate molecules to bind to the receptor and to open its channel, n, can be from 1 to 4, assuming that a receptor is a tetrameric complex and each subunit has one glutamate binding site.2226 It is further assumed that a ligand does not dissociate from the open-channel state. The kop and kcl are the channel-opening and channel-closing rate constants, respectively. For simplicity and without contrary evidence, it is assumed that glutamate binds at all binding steps with equal affinity or K1, the intrinsic equilibrium dissociation constant. By this mechanism, eq 2 was derived.

kobs=kcl+kop(LL+K1)n (2)

In deriving eq 2, the rate of ligand binding was assumed to be fast relative to the rate of channel opening. This assumption is consistent with kinetic evidence that the whole-cell current rise (described in detail in the Results) follows a first-order rate law (eq 1) not only in this study but also in all of our previous studies of the channel-opening mechanism for other kainate receptors.18 From eq 2, a set of kcl and kop values as well as K1 were found to be correlated with a particular number of ligands (n) that bound to and subsequently opened the receptor channel.

Furthermore, K1 was independently estimated from the dose-response relationship, as in eq 3, which was also derived based on the general mechanism of channel opening described above. In eq 3, IM is the current per mole of receptor, RM is the number of moles of receptors on the cell surface, and Φ1 is the channel opening equilibrium constant.

IA=IMRMLnLn+Φ(L+K1)n (3)

It should be noted that n as in both eqs 2 and 3 is the number of glutamate molecules to bind to and open the channel, and is not the Hill coefficient. Like the Hill equation,27 eq 3 accounts for macroscopic current response to the entire range of against concentration. As such, eq 3, together with eq 2, does not take into account the contribution of different conductance levels and the change of conductance with increasing agonist occupation. Nonetheless, we found that the best fitted value of n to be 2 from the use of eq 2 and eq 3, as described in Results.

Unless otherwise noted, each data point shown in the plots of this study was an average of at least three measurements collected from at least three cells. Linear regression and nonlinear fitting were performed using Origin 7 (Origin Lab, Northampton, MA). Unless otherwise noted, standard error of the mean was reported.

RESULTS

Expression and Detection of Wild-Type GluK1-2a, Wild-type GluK1-2b and the Mutant GluK1-2b Channels by Whole-Cell Recording

We expected that the mutant GluK1-2b has a higher expression level and thus higher current amplitude than the wild-type GluK1-2b for the following reason: The mutant GluK1-2b was constructed to change the amino acid sequence of its ER retention signal so that its ER exit and surface expression would be enhanced compared with the wild-type GluK1-2b10. On the other hand, GluK1-2a does not contain the alternatively spliced C-terminal domain or the ER retention signal that exists in the wild-type GluK1-2b sequence. If the ER retention sequence motif regulates only the receptor trafficking and cell surface expression, we expect that the wild-type GluK1-2a, wild-type GluK1-2b and the mutant GluK1-2b all have similar, if not identical, gating properties.

To test this hypothesis, we first measured the whole-cell current response of each of the receptors individually expressed in HEK-293 cells. As shown (Figure 1A), whole-cell current responses to glutamate at various concentrations initially increased as a result of channel activation, and then decreased towards baseline due to channel desensitization. Using the amplitude of whole-cell current (Figure 1B), we compared the relative surface expression level for the three receptors in HEK-293 cells. For this comparison, a total of 28 cells expressing the wild-type GluK1-2a, 11 cells expressing the wild-type GluK1-2b, and 15 cells expressing the mutant GluK1-2b were used, and the amount of plasmid we used for transient transfection was the same (24 μg per 35-mm dish).

FIGURE 1.

FIGURE 1

(A) Representative traces of whole-cell current measured from a single HEK-293 cell expressing the mutant GluK1. Glutamate was applied at time zero, and the concentrations of glutamate were, from bottom up, 10, 1, 0.2 and 0.1 mM, respectively. (B) Average of the whole-cell current amplitudes of the wild-type GluK1-2a (hallow column), wild-type GluK1-2b (solid column) and the mutant GluK1-2b (shaded column). The number of cells used for comparison for each receptor was described in the text.

The average whole-cell current amplitude at each of the three glutamate concentrations (0.05, 0.2 and 3 mM) for the mutant GluK1-2b was >5-fold larger than the wild-type GluK1-2b (Figure 1B). The highest current response, as we observed, of the GluK1-2b mutant to 3 mM glutamate is ~2 nA. These observations are comparable with those reported by Ren et al10 previously. In the study by Ren et al.,10 the GluK1-2b mutants tested contain at most three mutations (i.e., R896A, R900A, K901A). The mutant we tested contains an additional mutation or R896A besides R897A, R900A and K901A. Furthermore, the average of the whole cell current amplitude for the wild-type GluK1-2a was only slightly higher than the wild-type GluK1-2b (Figure 1B). The average whole-cell current response of GluK1-2a to 3 mM glutamate in our experiments (Figure 1B) was only ~800 pA. This value is comparable with those documented in the literature, i.e., 300–800 pA.6, 9, 12, 14, 28 This result may suggest a different regulatory process for surface expression of GluK1-2a10.

Dependence of the Whole-Cell Current Response on Glutamate Concentration

The dose-response relationship for the two wild-type and the mutant GluK1 receptors was characterized in order to estimate the K1 (i.e., the intrinsic equilibrium dissociation constant of the ligand) and the EC50 value. As seen in Figure 2A, the dose-response relationships of the wild-type GluK1-2a, wild-type GluK1-2b and the mutant 1–2b receptors were statistically indistinguishable. Quantitatively, the best fit of the combined dose-response data by eq 3 yielded K1 of 480 ± 50 μM (Figure 2A and Table 1) with n = 2 (here n represents the number of ligand molecules bound to the receptor to open the channel; Table 1 also contains the best fit values of K1 for n = 1, 3, and 4). When the dose-response curve was analyzed separately using the same approach, K1 was 400 ± 170 μM for the wild-type GluK1-2a, 470 ± 130 μM for the wild-type GluK1-2b, and 530 ± 140 μM for the mutant receptor, respectively (data not shown). From the same dose-response data, we also estimated the EC50 value by the Hill equation.27 We found that EC50 = 460 ± 34 μM, and the Hill coefficient = 1.1 ± 0.1 (Figure S2) for the combined dose-response data. When the dose-response relationships of the two wild-type and the mutant GluK1 receptors were analyzed separately, the EC50 value and the Hill coefficient were 510 ± 40 μM and 1.2 ± 0.1 for the wild-type GluK1-2a, 415 ± 30 μM and 1.0 ± 0.1 for the wild-type GluK1-2b, and 570 ± 70 μM and 1.1 ± 0.1 for the mutant GluK1-2b, respectively (data not shown). Based on these results, we concluded that the wild-type and mutant GluK1-2b as well as the wild-type GluK1-2a had an identical dose-response relationship. They also had the same n value from the best fit, namely, the number of glutamate molecules bound to and open the channel was 2. This value was corroborated by the fitting of both the dose-response data (Figure 2A, Table 1) and the channel-opening rate data, described below. Furthermore, the EC50 value of 510 ± 40 μM for GluK1-2a, which we determined, is similar to the EC50 of 631 μM for the same receptor reported by Sommer et al.9 (Table S1). However, no EC50 value for GluK1-2b or any of its mutants has been previously reported.

FIGURE 2.

FIGURE 2

(A) Dose-response relationship of the wild-type GluK1-2a (circle), wild-type GluK1-2b (square) and the mutant GluK1 receptors (triangle). Each data point is an average of at least three measurements from three different cells. A total of 53 cells were measured for the two wild-type and the mutant GluK1 receptors. The whole-cell current amplitudes from different cells were normalized to that of the control or 0.5 mM glutamate, and the average of the current amplitude collected from ≥5 mM glutamate concentrations was set to be 100%. The solid line is the nonlinear fit of the combined data based on eq 3 (see the detailed results of the fitting in Table 1). From the combined data, when n = 2, K1 of 480 ± 50 µM, Φ of 0.45 ± 0.15 and IMRM of 146 ± 20 were obtained. (B) Dependence of desensitization rate constant on glutamate concentration for the wild-type GluK1-2a (circle), wild-type GluK1-2b (square) and the mutant GluK1 receptors (triangle). Each data is an average of at least three data points from three cells.

Table 1.

Nonlinear fitting of the dose-response curve for the wild-type and mutant GluKl

na K1 (nm) Φ IMRM (nA) R2
1 1.63± 0.16 0.51 ± 0.05 161 ± 7 0.99
2 0.48 ± 0.05 0.45 ± 0.15 146 ± 20 0.97
3 0.26 ± 0.06 0.38 ± 0.16 137 ± 22 0.95
4 0.18 ± 0.03 0.43 ± 0.21 142 ± 28 0.94
a

n was fixed as an integer.

Dependence of Desensitization Rate Constant on Glutamate Concentration

Next we examined the desensitization rate (as shown in Figure 1A). The desensitization proceeded with a single, first-order rate process for >98% of the reaction and for the entire range of glutamate concentrations for all three receptors. The desensitization rate constant, or kdes, for the two wild-type receptors and the mutant GluK1 increased with increasing glutamate concentration but reached a plateau around 5 mM glutamate (Figure 2B). We found that the channel-desensitization rate profile or the dependence of the channel desensitization rate constant on glutamate concentration appeared to be identical (Figure 2B). The maximum kdes was 464 s−1 for the wild-type GluK1-2a, 450 s−1 for the wild-type GluK1-2b and 457 s−1 for the mutant (Figure 2B), respectively. These results showed that all three receptors desensitized with an identical rate constant at any given glutamate concentration (Figure 2B). Therefore, our results suggest that the difference in the amino acid sequence among the wild-type GluK1-2a, wild-type GluK1-2b and the mutant GluK1-2b (Figure S1) did not affect the channel desensitization kinetics.

The maximum kdes of 464 s−1 for the wild-type GluK1-2a we determined is in good agreement with the rate constant for the fast-desensitizing process of the same receptor reported previously.15 We did not, however, observe a slow-desensitizing rate as previously documented15 (note that the total number of cells we recorded was 28). The magnitude of the kdes that we determined for the mutant GluK1-2b of 457 s−1 is also similar to the value reported by Ren et al.10 for another GluK1-2b mutant with three point mutations (i.e., R896A, R900A, K901A). We did observe that ~20% of cells (from a total of 20 cells) that expressed the wild-type GluK1-2b showed a slower desensitization rate. The rate constant for the slow desensitization rate was 3.8-fold, 4.0-fold and 4.4-fold smaller collected at 50 μM, 200 μM and 3 mM glutamate concentrations, respectively (data not shown). However, on average, our ratio is ~2-fold larger than the one reported earlier.15 In contrast, only one cell (out of 25 cells) that expressed the mutant GluK1-2b exhibited a slower rate of desensitization. It should be noted that we did not study any of these slow-desensitizing cells that expressed either the wild-type GluK1-2b or its mutant.

Channel-Opening Rate Constants

Using the laser-pulse photolysis technique,17 we measured the channel-opening (kop) and channel-closing (kcl) rate constants for the wild-type GluK1-2a, wild-type GluK1-2b and the mutant GluK1-2b receptors. The magnitude of kop reflects how fast a channel opens after the binding of agonist, whereas the magnitude of kcl reflects how long a channel stays open or the lifetime of the open channel.19 Therefore, a putative difference between rate constants would be attributed to the difference in the amino acid sequence of the C-termini among the three receptors (Figure S1).

As seen in an example (Figure 3A), laser-pulse photolysis of the caged glutamate triggered a rapid rise of whole-cell current. The time course of the rising phase (Figure 3A), represented by an observed rate constant of channel opening, or kobs, was adequately described by a single exponential rate process (see the solid line as the fit to this rate process in Figure 3A by eq 1). Various kobs values were obtained as a function of the concentration of photolytically released glutamate. Inspection of these kobs values in relation to the range of glutamate concentrations showed that there was not a statistically significant difference among the two wild-type and the mutant GluK1 channels (Figure 3B). The best fit, using eq 2, of kobs as a function of the glutamate concentration, based on the combined data from the mutant and the two wild-type receptors, yielded that n was 2, and the kop and kcl values were (2.6 ± 0.1) × 104 s−1 and (1.1 ± 0.2) × 103 s−1, respectively (Figure 3B and Table 2). If the rate data were analyzed separately, the best fit yielded kop and kcl of (2.2 ± 0.2) × 104 s−1 and (0.9 ± 0.2) × 103 s−1 for the wild-type GluK1-2a, (2.4 ± 0.1) × 104 s−1 and (1.4 ± 0.2) × 103 s−1 for the wild-type GluK1-2b, and (0.8 ± 0.3) × 104 s−1 and (2.6 ± 0.3) × 103 s−1 for the mutant GluK1, respectively, at n = 2. We therefore conclude that GluK1-2a, GluK1-2b and the GluK1-2b mutant had identical kop and kcl values. These results suggest that the difference in the amino acid sequence located in the C-terminal tail that defines the wild-type GluK1-2a and the ER retention signal motif as in the wild-type sequence of GluK1-2b (Figure S1) does not affect the channel-opening rate process (Figure 3B, and Table 2).

FIGURE 3.

FIGURE 3

(A) A representative whole-cell current trace generated by the laser-pulse photolysis measurement with an HEK-293 cell expressing the wild-type GluK1-2a. A pulse of laser was fired at time zero. The concentration of glutamate released was estimated to be 180 µM. A kobs was calculated from the rising phase of the current to be 3,300 ± 76 s−1 by using eq 1 (the solid line). Note that the current is plotted opposite to the direction that was recorded. (B) Linear plot of the kobs data combined from the two wild-type and mutant GluK1 receptors as a function of glutamate concentration by eq 2. Each data point represents a single kobs value obtained at a particular concentration of photolytically released glutamate. Overall, a total of 20, 22 and 30 cells were measured for the wild-type GluK1-2a (circle), wild-type GluK1-2b (square) and the mutant GluK1-2b (triangle), respectively. The best linear fit yielded, at n = 2, kop and kcl of (2.4 ± 0.1) × 104 s−1 and (1.0 ± 0.2) × 103 s−1, respectively.

Table 2.

Fitted kop and kcl with different n values for the wild-type and mutant GluKl

na kop (× 104 s−1) kcl (× 103 s−1) R2
1 1.5 ± 0.1 − 0.7 ± 0.2 0.91
2 2.6 ± 0.1 1.1 ± 0.2 0.91
3 5.5 ± 0.3 1.7 ± 0.1 0.89
4 11.7 ± 0.8 2.1 ± 0.1 0.85
a

n was chosen as an integer, and K1 was chosen to be 480 μM

Estimation of (a) the Minimal Number of Glutamate Molecules Bound to a Receptor to Open its Channel and (b) the K1 Value Using the Rate Data

In the study described above (Figure 3), we measured kobs for the two wild-type receptors and the mutant GluK1 using up to 400 μM of glutamate generated by laser photolysis, which correlated with up to 52% of the fraction of the open-channel population. The wide range of kobs values vs. glutamate concentration permitted us to simultaneously evaluate, by eq 2, kop and K1 as well as n, the number of glutamate molecules bound to the receptor to open the channel. To achieve a better estimate of n, K1, and kop by nonlinear regression using eq 2, we decided to first fix the value of kcl. This is reasonable because when L << K1, eq 2 can be reduced to kobskcl, suggesting that (a) kobs at a low glutamate concentration would reflect kcl, and (b) the value of kcl is independent of the n value, as in eq 2.19, 29 Based on this rationale, we identified kobs of 1,000 s−1, determined at ~60 μM glutamate concentration or ~4% fraction of the open channel,19 to be kcl for the wild-type and mutant GluK1 receptors. By nonlinear regression with kcl = 1,000 s−1, the n values turned out to be consistently close to 2 (Table S2). Furthermore, choosing kcl values different from 1,000 s−1 did not significantly affect the output of n, K1 or kop values (Table 3). These results are therefore consistent with n = 2 being the best fit (Table 3). This conclusion is also consistent with results from our study of other kainate receptor channels.17, 19, 21, 30 Furthermore, as is known for kainate receptors, channel activation via a subset of subunits instead of all four in a tetrameric complex can indeed occur.31 Thus, we favor an interpretation of kop and kcl at n = 2 being the representative values of the channel-opening and channel-closing rate constants for the wild-type GluK1-2a, wild-type GluK1-2b and the mutant GluK1-2b receptors.

Table 3.

Nonlinear fitting of the wild-type and mutant GluKl data for estimating n, kop and K1

kcla (s−1) n kop (× 103 s−1) K1 (mM) R2
400 1.8 ± 0.4 2.7± 0.4 0.44 ± 0.17 0.80
600 1.9 ± 0.5 2.6 ± 0.3 0.44 ± 0.16 0.81
800 2.0 ± 0.6 2.4 ± 0.3 0.43 ± 0.15 0.83
1000 2.1 ± 0.5 2.3 ± 0.3 0.43 ± 0.15 0.83
1200 2.0 ± 0.5 2.5 ± 0.4 0.48 ± 0.15 0.84
1400 2.0 ± 0.6 2.5 ± 0.4 0.51 ± 0.17 0.82
a

kcl is fixed as specified

The evaluation of n as described above was based on the channel-opening rate data, independent of the analysis of the dose-response relationship (as in Figure 2A). Using the same rate data, we also independently evaluated K1, the intrinsic equilibrium dissociation constant (see the scheme in Experimental Procedures). Specifically, nonlinear regression of kobs vs. glutamate concentration using eq 2 yielded an average of K1 of 400 ± 150 μM for the wild-type GluK1-2a, wild-type GluK1-2b and the mutant GluK1-2b receptors (Table S1). This value was in good agreement with the K1 value of 480 ± 50 μM obtained from the dose-response measurement (Figure 2A and Table 1). When K1 was further constrained to be 480 μM, in addition to a fixed kcl, the fitted values of n were, again, close to 2, and the fitted values of kop were relatively invariant, the average of which was 2.6 × 104 s−1 (Table S3). Finally, if kcl and n were kept at 1,000 s−1 and 2, respectively, we obtained kop = 2.1 × 104 s−1 on average. Similarly, K1 was found to be 380 μM (Table S4). It should be noted that the K1 value, which was obtained from the channel-opening rate data, was also in agreement with the K1 value obtained independently from the dose-response relationship.

Measurement of the Channel-Opening Rate Constant

To characterize the mechanism of channel opening for the GluK1 receptors, we took into account several experimental observations in our kinetic data analysis to obtain kop and kcl. For example, the rising phase of the whole-cell current (as in Figure 3A) proceeded with a single exponential rate law in the entire concentration range of glutamate (i.e., 60–400 μM). This observation was consistent with the assumption that the channel-opening rate or the rate of transition from the closed-channel form, ALn, to the open-channel form, ALn¯, was slow compared with all preceding steps involving glutamate binding. On the basis of this assumption, eq 2 was derived. If the channel-opening rate was either comparable to or faster than the ligand-binding rate, a single-exponential rate law would fail. For instance, when the ligand concentration is too low such that the ligand association rate dominates the rate process, the rising phase of the current will represent a bi-molecular association rate process instead.19, 30 To ensure that ligand binding was fast even at low glutamate concentrations, we did not use any kobs values at any glutamate concentrations lower than ~4% of the fraction of the open-channel form.19 For GluK1 receptors, 4% of the fraction of the open-channel form correlates with ~60 μM of glutamate (see the dose-response relation). Under this condition kobs reflected mainly kcl.19 To demonstrate that the method of data analysis used here is valid, we note that the kcl values,19, 30 calculated using eq 2 and by using ~4% of the fraction of the open-channel form, are generally in agreement with the lifetimes determined by single-channel recording of the same α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) channels with glutamate as the agonist (i.e., kcl = 1/τ and τ is the lifetime expressed as time constant).17, 19, 24, 32

Swanson et al33 previously studied the homomeric GluK1 receptors using single-channel recording. In the presence of domoate as the agonist, GluK1 channels exhibited three conductance states, and two time constants, i.e., 0.3 ms and 0.7 ms, from the best fit of the open-time distribution. These time constants are equivalent to the rate constants of ~3,300 s−1 and 1,400 s−1, respectively. However, no single-channel study of any GluK1 receptors using glutamate as the agonist has been reported thus far. Furthermore, the kop and kcl values of GluK1 receptor channels we determined in this study, together with K1 and EC50 and n values, were based on macroscopic current response to glutamate. Consequently, the kop and kcl values only reflect the average rate constants of an ensemble of single channels or they do not correlate to kinetic constants of individual channels of the ensemble.

DISCUSSION

In this study, we characterized the channel-opening mechanism for three kainate receptors, namely the wild-type GluK1-2a, wild-type GluK1-2b and a GluK1-2b receptor mutated at the C-terminal tail such that the ER retention signal is disrupted. As expected, the wild-type GluK1-2a and the GluK1-2b mutant receptors that lack the ER retention signal motif are expressed better in HEK-293 cells than the wild-type GluK1-2b. Furthermore, the wild-type GluK1-2a and the mutant GluK1-2b share identical kdes, kop, kcl and K1, as well as EC50 values with the wild-type GluK1-2b. The minimal number of glutamate molecules that bind to any one of the three receptors in order to open the channel is two. Because all three GluK1 receptors have different amino acid sequences in the C-terminal region but identical sequences elsewhere, our results suggest that the C-terminal region, precisely the sequence surrounding the ER-retention and trafficking signal, does not affect the channel-gating properties of GluK1. Our results therefore demonstrate that the GluK1-2b mutant can be used to represent the GluK1-2a and GluK1-2b wild-type receptors in studying their structure-function relationships. Having a better expressed mutant and consequently larger whole-cell current response would be further advantageous for studying the function and the regulation of the GluK1 receptors. The fact that the mutant GluK1-2b receptor produces larger current response but has identical kinetic properties to those of the wild-type GluK1-2a and GluK1-2b further suggests a possibility of finding additional mutants, by changing the amino acid sequences within or near the ER retention/trafficking signal, that express even better in HEK-293 cells and produce an even larger whole-cell current response.

The results from this study using the rat GluK1 receptor now allow us to make comparisons with results obtained for the rat GluK2, the most studied and the best understood kainate receptor channel to date.12, 18, 21, 3437 The K1 of 300 ± 210 μM for the rat GluK2 defined previously21 is similar to the K1 of 400 ± 150 μM (from the analysis of the combined rate-constant data) and the K1 of 480 ± 50 μM for the rat GluK1 (from the analysis of the combined dose-response relation data), suggesting that there is no significant difference between the dose-response relationships of GluK1 and GluK2. Because the peak concentration of glutamate in the synapse cleft is thought to be about 1 mM,38, 39 both GluK1 and GluK2 kainate receptors can open up to 80% of the receptors under this condition. In other words, both receptors have equal sensitivity to glutamate.21 Conversely, the channel-opening and channel-closing rate constants of GluK2, i.e., (6.4 ± 0.3) × 103 s−1 and (3.9 ± 0.3) × 102 s−1, respectively,21 are several-fold smaller than those of the GluK1 receptors reported here. This comparison suggests that the GluK1 channels open, in response to glutamate, and close several-fold faster than the GluK2 receptor channel. Furthermore, the maximum desensitization rate constant of the GluK1 channels we report here is almost two-fold larger than that of the rat GluK2 channels21 (i.e., kdes = ~460 s−1 vs. ~230 s−1). Taken together, our results show that the GluK1 homomeric receptor is a faster kainate channel followed by the binding of glutamate than GluK2, in that the channel opens, closes, and desensitizes faster than GluK2 does. The apparent difference in the channel-gating properties between GluK1 and GluK2 may be surprising, because the two subunits share ~80% sequence identity, and such extensive sequence homology generally suggests common properties.

The rapid kinetic characterization of the GluK1 kainate receptor that we have described here represents our continuing effort to characterize the similarities and differences in the channel-opening kinetic properties between the kainate and AMPA receptor subtypes. In a more significant way, the results from this study demonstrate that GluK1 receptors exhibit a much slower rate of channel opening in response to glutamate binding and a slower rate of closing the open channels than do AMPA receptors.17, 19, 30, 40, 41 The desensitization rate constant of GluK1 is, however, comparable to those of AMPA receptors.17, 19, 30, 40, 41 Specifically, the maximum kdes is much faster than that of either the flip or the flop isoform of the GluA1 AMPA receptor channel but is comparable to that of the GluA2Qflop AMPA receptor channel, which is much faster than GluA2Qflip. The K1 or EC50 values for both GluK1 and GluK218, 21 are comparable to that of the GluA1 AMPA receptor, but are about two-fold smaller than the corresponding values for the rest of the AMPA receptor homomeric channels17, 19, 30, 40, 41 Therefore, the results from this study and the studies we reported before18, 21 support that kainate receptors (i.e., GluK1 and GluK2) have different channel properties as compared with AMPA receptors.

The results for GluK1, together with the results for GluK2,21 show that kainate receptors are kinetically slower than AMPA receptors to open the channel. This conclusion may be useful in understanding the role of kainate receptors, which is much less understood than the role of AMPA receptors, in mediating synaptic plasticity.3, 5, 42 For example, our results may account for the slower time course of the rise and decay of the kainate-mediated excitatory postsynaptic currents (EPSCs) than the AMPA receptor-mediated EPSCs, as observed in hippocampal CA3 pyramidal cells.4345 The time course of this mixed AMPA and kainate EPSCs is similar to those reported for synapses on CA1 hippocampal interneurons46, 47 and in layer-IV neurons of the primary somatosensory cortex.48 The difference in the channel-opening kinetic properties, defined by those rate constants, between kainate and AMPA receptors could be an explanation of different EPSC profiles.18 Therefore, our results support the hypothesis that kainate receptors encode different ranges of afferent fiber frequency as compared with AMPA receptors.4951 A relatively slow kainate-receptor mediated EPSCs can be also ascribed to kinetic behaviors of heteromeric kainate receptors.52 It is known, for instance, that GluK1/GluK5 has different gating properties as compared with GluK1 homoeric channels.33 Association of auxiliary proteins with kainate receptors is also known to slow the decaying of EPSCs53, 54. Therefore, similar studies of channel-opening kinetic properties of both heteromeric kainate channels and protein-kainate receptor complexes will be helpful for a better understanding of the kainate-receptor mediated synaptic neurotransmission.

Supplementary Material

1_si_001

ACKNOWLEDGEMENTS

We thank Peter Seeburg for the wild-type GluK1-2a DNA plasmid, and Geoffrey Swanson for the GluK1-2b DNA plasmids.

Funding This work was supported by grants from NIH/NINDS (R01 NS060812), Department of Defense (W81XWH-04-1-0106) and the Muscular Dystrophy Association (to L.N.).

ABBREVIATIONS

AMPA

α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

EPSCs

excitatory postsynaptic currents

ER

endoplasmic reticulum

HEK-293 cells

human embryonic kidney 293 cells

Footnotes

Supporting Information The supporting information includes a schematic figure showing the C-termini of the GluK1 receptor isoforms, a Hill equation fit to the dose-response relationship, and several tables showing the results of the nonlinear regression data for the best fit of n,K1 and kop to the observed rate constant of channel opening as a function of glutamate concentration. This material is available free of charge via the Internet at http://pubs.acs.org.

REFERENCES

  • 1.Contractor A, Mulle C, Swanson GT. Kainate receptors coming of age: milestones of two decades of research. Trends Neurosci. 2011;34:154–163. doi: 10.1016/j.tins.2010.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Perrais D, Veran J, Mulle C. Gating and permeation of kainate receptors: differences unveiled. Trends in pharmacological sciences. 2010;31:516–522. doi: 10.1016/j.tips.2010.08.004. [DOI] [PubMed] [Google Scholar]
  • 3.Jane DE, Lodge D, Collingridge GL. Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology. 2009;56:90–113. doi: 10.1016/j.neuropharm.2008.08.023. [DOI] [PubMed] [Google Scholar]
  • 4.Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev. 1999;51:7–61. [PubMed] [Google Scholar]
  • 5.Lerma J. Kainate receptor physiology. Curr Opin Pharmacol. 2006;6:89–97. doi: 10.1016/j.coph.2005.08.004. [DOI] [PubMed] [Google Scholar]
  • 6.Lerma J, Paternain AV, Rodriguez-Moreno A, Lopez-Garcia JC. Molecular physiology of kainate receptors. Physiol Rev. 2001;81:971–998. doi: 10.1152/physrev.2001.81.3.971. [DOI] [PubMed] [Google Scholar]
  • 7.Collingridge GL, Olsen R, Peters JA, Spedding M. Ligand gated ion channels. Neuropharmacology. 2009;56:1. doi: 10.1016/j.neuropharm.2008.08.036. [DOI] [PubMed] [Google Scholar]
  • 8.Bettler B, Boulter J, Hermans-Borgmeyer I, O'Shea-Greenfield A, Deneris ES, Moll C, Borgmeyer U, Hollmann M, Heinemann S. Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development. Neuron. 1990;5:583–595. doi: 10.1016/0896-6273(90)90213-y. [DOI] [PubMed] [Google Scholar]
  • 9.Sommer B, Burnashev N, Verdoorn TA, Keinanen K, Sakmann B, Seeburg PH. A glutamate receptor channel with high affinity for domoate and kainate. EMBO J. 1992;11:1651–1656. doi: 10.1002/j.1460-2075.1992.tb05211.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ren Z, Riley NJ, Needleman LA, Sanders JM, Swanson GT, Marshall J. Cell surface expression of GluR5 kainate receptors is regulated by an endoplasmic reticulum retention signal. J Biol Chem. 2003;278:52700–52709. doi: 10.1074/jbc.M309585200. [DOI] [PubMed] [Google Scholar]
  • 11.Christensen JK, Varming T, Ahring PK, Jorgensen TD, Nielsen EO. In vitro characterization of 5-carboxyl-2,4-di-benzamidobenzoic acid (NS3763), a noncompetitive antagonist of GLUK5 receptors. J Pharmacol Exp Ther. 2004;309:1003–1010. doi: 10.1124/jpet.103.062794. [DOI] [PubMed] [Google Scholar]
  • 12.Swanson GT, Gereau R. W. t., Green T, Heinemann SF. Identification of amino acid residues that control functional behavior in GluR5 and GluR6 kainate receptors. Neuron. 1997;19:913–926. doi: 10.1016/s0896-6273(00)80972-1. [DOI] [PubMed] [Google Scholar]
  • 13.Ritz M, Micale N, Grasso S, Niu L. Mechanism of inhibition of the GluR2 AMPA receptor channel opening by 2,3-benzodiazepine derivatives. Biochemistry. 2008;47:1061–1069. doi: 10.1021/bi700782x. [DOI] [PubMed] [Google Scholar]
  • 14.Swanson GT, Green T, Heinemann SF. Kainate receptors exhibit differential sensitivities to (S)-5-iodowillardiine. Mol Pharmacol. 1998;53:942–949. [PubMed] [Google Scholar]
  • 15.Swanson GT, Heinemann SF. Heterogeneity of homomeric GluR5 kainate receptor desensitization expressed in HEK293 cells. J Physiol. 1998;513(Pt 3):639–646. doi: 10.1111/j.1469-7793.1998.639ba.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wieboldt R, Gee KR, Niu L, Ramesh D, Carpenter BK, Hess GP. Photolabile precursors of glutamate: synthesis, photochemical properties, and activation of glutamate receptors on a microsecond time scale. Proc Natl Acad Sci U S A. 1994;91:8752–8756. doi: 10.1073/pnas.91.19.8752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Li G, Pei W, Niu L. Channel-opening kinetics of GluR2Q(flip) AMPA receptor: a laser-pulse photolysis study. Biochemistry. 2003;42:12358–12366. doi: 10.1021/bi0347961. [DOI] [PubMed] [Google Scholar]
  • 18.Li G, Oswald RE, Niu L. Channel-opening kinetics of GluR6 kainate receptor. Biochemistry. 2003;42:12367–12375. doi: 10.1021/bi034797t. [DOI] [PubMed] [Google Scholar]
  • 19.Li G, Niu L. How fast does the GluR1Qflip channel open? J Biol Chem. 2004;279:3990–3997. doi: 10.1074/jbc.M310410200. [DOI] [PubMed] [Google Scholar]
  • 20.Canepari M, Nelson L, Papageorgiou G, Corrie JE, Ogden D. Photochemical and pharmacological evaluation of 7-nitroindolinyl-and 4-methoxy-7-nitroindolinyl-amino acids as novel, fast caged neurotransmitters. J Neurosci Methods. 2001;112:29–42. doi: 10.1016/s0165-0270(01)00451-4. [DOI] [PubMed] [Google Scholar]
  • 21.Han Y, Wang C, Park JS, Niu L. Channel-opening kinetic mechanism for human wild-type GluK2 and the M867I mutant kainate receptor. Biochemistry. 2010;49:9207–9216. doi: 10.1021/bi100819v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Mano I, Teichberg VI. A tetrameric subunit stoichiometry for a glutamate receptor-channel complex. Neuroreport. 1998;9:327–331. doi: 10.1097/00001756-199801260-00027. [DOI] [PubMed] [Google Scholar]
  • 23.Rosenmund C, Stern-Bach Y, Stevens CF. The tetrameric structure of a glutamate receptor channel. Science. 1998;280:1596–1599. doi: 10.1126/science.280.5369.1596. [DOI] [PubMed] [Google Scholar]
  • 24.Jin R, Gouaux E. Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal. Biochemistry. 2003;42:5201–5213. doi: 10.1021/bi020632t. [DOI] [PubMed] [Google Scholar]
  • 25.Mansour M, Nagarajan N, Nehring RB, Clements JD, Rosenmund C. Heteromeric AMPA receptors assemble with a preferred subunit stoichiometry and spatial arrangement. Neuron. 2001;32:841–853. doi: 10.1016/s0896-6273(01)00520-7. [DOI] [PubMed] [Google Scholar]
  • 26.Sobolevsky AI, Rosconi MP, Gouaux E. X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature. 2009;462:745–756. doi: 10.1038/nature08624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Loftfield RB, Eigner EA. Molecular order of participation of inhibitors (or activators) in biological systems. Science. 1969;164:305–308. doi: 10.1126/science.164.3877.305. [DOI] [PubMed] [Google Scholar]
  • 28.Lash LL, Sanders JM, Akiyama N, Shoji M, Postila P, Pentikainen OT, Sasaki M, Sakai R, Swanson GT. Novel analogs and stereoisomers of the marine toxin neodysiherbaine with specificity for kainate receptors. J Pharmacol Exp Ther. 2008;324:484–496. doi: 10.1124/jpet.107.129890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Pei W, Ritz M, McCarthy M, Huang Z, Niu L. Receptor occupancy and channel-opening kinetics: a study of GLUR1 L497Y AMPA receptor. J Biol Chem. 2007;282:22731–22736. doi: 10.1074/jbc.M611821200. [DOI] [PubMed] [Google Scholar]
  • 30.Pei W, Huang Z, Wang C, Han Y, Park JS, Niu L. Flip and flop: a molecular determinant for AMPA receptor channel opening. Biochemistry. 2009;48:3767–3777. doi: 10.1021/bi8015907. [DOI] [PubMed] [Google Scholar]
  • 31.Swanson GT, Green T, Sakai R, Contractor A, Che W, Kamiya H, Heinemann SF. Differential activation of individual subunits in heteromeric kainate receptors. Neuron. 2002;34:589–598. doi: 10.1016/s0896-6273(02)00676-1. [DOI] [PubMed] [Google Scholar]
  • 32.Derkach V, Barria A, Soderling TR. Ca2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proc Natl Acad Sci U S A. 1999;96:3269–3274. doi: 10.1073/pnas.96.6.3269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Swanson GT, Feldmeyer D, Kaneda M, Cull-Candy SG. Effect of RNA editing and subunit co-assembly single-channel properties of recombinant kainate receptors. J Physiol. 1996;492(Pt 1):129–142. doi: 10.1113/jphysiol.1996.sp021295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Heckmann M, Bufler J, Franke C, Dudel J. Kinetics of homomeric GluR6 glutamate receptor channels. Biophys J. 1996;71:1743–1750. doi: 10.1016/S0006-3495(96)79375-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Mayer ML. Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity. Neuron. 2005;45:539–552. doi: 10.1016/j.neuron.2005.01.031. [DOI] [PubMed] [Google Scholar]
  • 36.Mayer ML, Ghosal A, Dolman NP, Jane DE. Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists. J Neurosci. 2006;26:2852–2861. doi: 10.1523/JNEUROSCI.0123-06.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Yan S, Sanders JM, Xu J, Zhu Y, Contractor A, Swanson GT. A C-terminal determinant of GluR6 kainate receptor trafficking. J Neurosci. 2004;24:679–691. doi: 10.1523/JNEUROSCI.4985-03.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Clements JD, Lester RA, Tong G, Jahr CE, Westbrook GL. The time course of glutamate in the synaptic cleft. Science. 1992;258:1498–1501. doi: 10.1126/science.1359647. [DOI] [PubMed] [Google Scholar]
  • 39.Colquhoun D, Jonas P, Sakmann B. Action of brief pulses of glutamate on AMPA/kainate receptors in patches from different neurones of rat hippocampal slices. J Physiol. 1992;458:261–287. doi: 10.1113/jphysiol.1992.sp019417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Li G, Sheng Z, Huang Z, Niu L. Kinetic mechanism of channel opening of the GluRDflip AMPA receptor. Biochemistry. 2005;44:5835–5841. doi: 10.1021/bi047413n. [DOI] [PubMed] [Google Scholar]
  • 41.Pei W, Huang Z, Niu L. GluR3 flip and flop: differences in channel opening kinetics. Biochemistry. 2007;46:2027–2036. doi: 10.1021/bi062213s. [DOI] [PubMed] [Google Scholar]
  • 42.Mellor JR. Synaptic plasticity of kainate receptors. Biochem Soc Trans. 2006;34:949–951. doi: 10.1042/BST0340949. [DOI] [PubMed] [Google Scholar]
  • 43.Cossart R, Epsztein J, Tyzio R, Becq H, Hirsch J, Ben-Ari Y, Crepel V. Quantal release of glutamate generates pure kainate and mixed AMPA/kainate EPSCs in hippocampal neurons. Neuron. 2002;35:147–159. doi: 10.1016/s0896-6273(02)00753-5. [DOI] [PubMed] [Google Scholar]
  • 44.Castillo PE, Malenka RC, Nicoll RA. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature. 1997;388:182–186. doi: 10.1038/40645. [DOI] [PubMed] [Google Scholar]
  • 45.Vignes M, Bleakman D, Lodge D, Collingridge GL. The synaptic activation of the GluR5 subtype of kainate receptor in area CA3 of the rat hippocampus. Neuropharmacology. 1997;36:1477–1481. doi: 10.1016/s0028-3908(97)00158-5. [DOI] [PubMed] [Google Scholar]
  • 46.Cossart R, Esclapez M, Hirsch JC, Bernard C, Ben-Ari Y. GluR5 kainate receptor activation in interneurons increases tonic inhibition of pyramidal cells. Nat Neurosci. 1998;1:470–478. doi: 10.1038/2185. [DOI] [PubMed] [Google Scholar]
  • 47.Frerking M, Malenka RC, Nicoll RA. Synaptic activation of kainate receptors on hippocampal interneurons. Nat Neurosci. 1998;1:479–486. doi: 10.1038/2194. [DOI] [PubMed] [Google Scholar]
  • 48.Kidd FL, Isaac JT. Developmental and activity-dependent regulation of kainate receptors at thalamocortical synapses. Nature. 1999;400:569–573. doi: 10.1038/23040. [DOI] [PubMed] [Google Scholar]
  • 49.Frerking M, Ohliger-Frerking P. AMPA receptors and kainate receptors encode different features of afferent activity. J Neurosci. 2002;22:7434–7443. doi: 10.1523/JNEUROSCI.22-17-07434.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Sachidhanandam S, Blanchet C, Jeantet Y, Cho YH, Mulle C. Kainate receptors act as conditional amplifiers of spike transmission at hippocampal mossy fiber synapses. J Neurosci. 2009;29:5000–5008. doi: 10.1523/JNEUROSCI.5807-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Goldin M, Epsztein J, Jorquera I, Represa A, Ben-Ari Y, Crepel V, Cossart R. Synaptic kainate receptors tune oriens-lacunosum moleculare interneurons to operate at theta frequency. J Neurosci. 2007;27:9560–9572. doi: 10.1523/JNEUROSCI.1237-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Barberis A, Sachidhanandam S, Mulle C. GluR6/KA2 kainate receptors mediate slow-deactivating currents. J Neurosci. 2008;28:6402–6406. doi: 10.1523/JNEUROSCI.1204-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Tang M, Pelkey KA, Ng D, Ivakine E, McBain CJ, Salter MW, McInnes RR. Neto1 is an auxiliary subunit of native synaptic kainate receptors. J Neurosci. 2011;31:10009–10018. doi: 10.1523/JNEUROSCI.6617-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Straub C, Hunt DL, Yamasaki M, Kim KS, Watanabe M, Castillo PE, Tomita S. Distinct functions of kainate receptors in the brain are determined by the auxiliary subunit Neto1. Nat Neurosci. 2011;14:866–873. doi: 10.1038/nn.2837. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES